PRESS RELEASES

Date	Title and Summary	Additional Formats
Toggle SummaryMar 28, 2008	Integra Foundation Awards Grant to Neuroscience Nursing Foundation PLAINSBORO, N.J., Mar 28, 2008 (PrimeNewswire via COMTEX News Network) -- The Integra Foundation, the philanthropic arm of Integra LifeSciences Corporation (Nasdaq:IART), has awarded a $25,000 grant to the Neuroscience Nursing Foundation (NNF) in support of three key programs - 1) Travel Grants,	View HTML Integra Foundation Awards Grant to Neuroscience Nursing Foundation 14.6 KB
Toggle SummaryApr 3, 2008	Integra Foundation Awards Grant to Association of Perioperative Nurses Foundation PLAINSBORO, N.J., Apr 3, 2008 (PrimeNewswire via COMTEX News Network) -- The Integra Foundation, the philanthropic arm of Integra LifeSciences Corporation (Nasdaq:IART), announced today that it has awarded a $25,000 grant to the Association of Perioperative Nurses (AORN) Foundation, to assist	View HTML Integra Foundation Awards Grant to Association of Perioperative Nurses Foundation 14.4 KB
Toggle SummaryAug 28, 2009	Integra Foundation Awards Grant to American Association of Neurological Surgeons Supports XIV World Congress of the World Federation of Neurosurgical Societies	View HTML Integra Foundation Awards Grant to American Association of Neurological Surgeons 15.4 KB
Toggle SummaryOct 19, 2004	Integra Epilepsy Products Receive CE Mark For Distribution in the European Union Integra Epilepsy(TM) Products Receive CE Mark For Distribution in the European Union PLAINSBORO, New Jersey, Oct. 19, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it was awarded the CE Mark required for commercial distribution of the Integra	View HTML Integra Epilepsy(TM) Products Receive CE Mark For Distribution in the European Union 11.3 KB
Toggle SummaryMay 18, 2004	Integra Epilepsy Products Featured at the 2004 National Teaching Institute & Critical Care Exposition Integra Epilepsy(TM) Products Featured at the 2004 National Teaching Institute & Critical Care Exposition PLAINSBORO, N.J., May 18, 2004 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it is featuring its recently launched Integra Epilepsy™ products at	View HTML Integra Epilepsy(TM) Products Featured at the 2004 National Teaching Institute & Critical Care Exposition 11.6 KB
Toggle SummaryApr 15, 2009	INTEGRA Dermal Regeneration Template Launched in Japan Receives Approval for Use in Life-Threatening Burns	View HTML INTEGRA Dermal Regeneration Template Launched in Japan 17.5 KB
Toggle SummarySep 22, 2008	Integra Announces the Addition of a Low Profile Shunt to the OSVII Flow-Regulating Shunts PLAINSBORO, N.J., Sep 22, 2008 (GlobeNewswire via COMTEX News Network) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced today the introduction of the OSVII Low Pro(TM) Valve, a low profile version of the OSVII(R) Flow-Controlled Hydrocephalus Valve.	View HTML Integra Announces the Addition of a Low Profile Shunt to the OSVII Flow-Regulating Shunts 18.2 KB
Toggle SummaryJun 9, 2011	Integra Announces Private Placement of Convertible Senior Notes PLAINSBORO, N.J., June 9, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced that it has commenced a private offering, subject to market conditions, of $200,000,000 aggregate principal amount of convertible senior notes due 2016.	View HTML Integra Announces Private Placement of Convertible Senior Notes 12 KB
Toggle SummaryJun 10, 2011	Integra Announces Pricing of Convertible Senior Notes PLAINSBORO, N.J., June 10, 2011 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the pricing of $200,000,000 aggregate principal amount of 1.625% convertible senior notes due 2016 (the "notes"). The notes were offered and sold in a private placement solely	View HTML Integra Announces Pricing of Convertible Senior Notes 12.3 KB
Toggle SummaryFeb 4, 2020	Integra Announces Pricing of Convertible Senior Notes PRINCETON, N.J., Feb. 04, 2020 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ:IART) today announced the pricing of $500,000,000 aggregate principal amount of 0.5% convertible senior notes due 2025 (the “Notes”). The Notes were offered and sold in a private placement solely to	View HTML PDF Version